It was shown that higher serum IGF-1 levels in middle age were associated with risk of Alzheimer’s disease in older age, independent of Apolipoprotein E (ApoE) genotype [31]. This evidence concerns the gene IGF1 and early-onset autosomal dominant Alzheimer disease.